Despite increase in referrals for mammography screening for high-risk women, actual screening numbers did not increase significantly.
Mammography screening numbers do not increase even after patients are told that they are at higher risk for breast cancer, according to a study published in the Journal of the American College of Radiology.
Researchers from Penn State Hershey Breast Center and Penn State Milton S. Hershey Medical Center in Hershey, PA, undertook a study to determine the effectiveness of introducing a standardized recommendation into mammography reports in order to recruit women who had a 20% or higher lifetime risk for breast cancer.
The study included patients who were screened in 2011 and 2013. The researchers reviewed the charts for annotations in the mammography reports addressing the patients' risk status and referral to a provider at the clinic.[[{"type":"media","view_mode":"media_crop","fid":"41000","attributes":{"alt":"","class":"media-image media-image-right","id":"media_crop_7593375620072","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"4259","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"height: 85px; width: 100px; border-width: 0px; border-style: solid; margin: 1px; float: right;","title":"©Sam72/Shutterstock.com","typeof":"foaf:Image"}}]]
The results showed that 173 patients in 2011 and 241 patients in 2013 fell into this high risk target group. In 2011, 40.5% of the women were given a recommendation to attend the risk assessment clinic, while 75.5% were recommended to in 2013. “Despite the overall increase in such recommendations by radiologists, only a modest increase occurred, from 11.4 percent to 14.3 percent, in patients that subsequently attended our risk assessment clinic,” the authors wrote.
The researchers concluded that even though physicians made more recommendations for screening to women at high risk of developing breast cancer, the actual number of screenings did not increase.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
Contrast-Enhanced Mammography and High-Concentration ICM Dosing: What a New Study Reveals
June 16th 2025New research showed a 96 to 97 percent sensitivity for contrast-enhanced mammography (CEM) with an increased iodine delivery rate facilitating robust contrast enhancement for women with aggressive breast cancer.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.